Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
7
PHGE Quote, Financials, Valuation and Earnings
Last price:
$4.69
Seasonality move
:
12.97%
Day range:
$4.47 - $4.81
52-week range:
$4.10 - $22.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
18.03x
Volume:
48.8K
Avg. volume:
84.9K
1-year change:
-60.26%
Market cap:
$6.9M
Revenue:
--
EPS (TTM):
-$30.68
Analysts' Opinion
-
Consensus RatingBiomX, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $399.00, BiomX, Inc. has an estimated upside of 8747.01% from its current price of $4.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $304.00 representing 100% downside risk from its current price of $4.77.
Fair Value
-
According to the consensus of 1 analyst, BiomX, Inc. has 8747.01% upside to fair value with a price target of $399.00 per share.
PHGE vs. S&P 500
-
Over the past 5 trading days, BiomX, Inc. has underperformed the S&P 500 by -21.98% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BiomX, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BiomX, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter BiomX, Inc. reported revenues of --.
Earnings Growth
-
BiomX, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter BiomX, Inc. reported earnings per share of -$5.55.
Enterprise value:
24.2M
EV / Invested capital:
1.42x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-0.85x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.7M
Return On Assets:
-69.56%
Net Income Margin (TTM):
--
Return On Equity:
-160.84%
Return On Invested Capital:
-116.24%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$1.3M | -$1.1M | -$2.7M | -$322K | -$1.2M | |
| Operating Income | -$25.6M | -$32.3M | -$33.1M | -$10.5M | -$8.5M | |
| EBITDA | -$24.4M | -$31.2M | -$30.4M | -$10.2M | -$7.3M | |
| Diluted EPS | -$3.59 | -$4.35 | -$30.68 | $0.31 | -$5.55 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $69.8M | $42.5M | $25.3M | $28.3M | $8.9M | |
| Total Assets | $81.8M | $51.9M | $33.1M | $60M | $26.2M | |
| Current Liabilities | $9M | $7.5M | $12.8M | $8.9M | $5.2M | |
| Total Liabilities | $28.4M | $25.3M | $24.9M | $22.1M | $15.7M | |
| Total Equity | $53.4M | $26.6M | $8.2M | $37.9M | $10.5M | |
| Total Debt | $19M | $18.7M | $15.6M | $8.7M | $5.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$22.2M | -$36.9M | -$28.3M | -$8.1M | -$7.2M | |
| Cash From Investing | $3.4M | $710K | $106K | -$1K | -$2K | |
| Cash From Financing | $4.2M | $37.4M | $11.5M | -- | $54K | |
| Free Cash Flow | -$22.3M | -$37M | -$28.3M | -$8.1M | -$7.2M | |
PHGE
Sector
Market Cap
$6.9M
$28.4M
Price % of 52-Week High
20.45%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-77.21%
-1.32%
1-Year Price Total Return
-62.02%
-22.19%
Beta (5-Year)
1.558
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.82
200-day SMA
Sell
Level
$9.76
Bollinger Bands (100)
Sell
Level
6.98 - 10.98
Chaikin Money Flow
Buy
Level
1.4M
20-day SMA
Sell
Level
$5.79
Relative Strength Index (RSI14)
Sell
Level
33.98
ADX Line
Sell
Level
43.33
Williams %R
Buy
Level
-87.4181
50-day SMA
Sell
Level
$8.58
MACD (12, 26)
Sell
Level
-1.21
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
13.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.4584)
Sell
CA Score
(Annual)
Level (-4.2068)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.1726)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
Stock Forecast FAQ
In the current month, PHGE has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PHGE average analyst price target in the past 3 months is $399.00.
-
Where Will BiomX, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that BiomX, Inc. share price will rise to $399.00 per share over the next 12 months.
-
What Do Analysts Say About BiomX, Inc.?
Analysts are divided on their view about BiomX, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BiomX, Inc. is a Sell and believe this share price will drop from its current level to $304.00.
-
What Is BiomX, Inc.'s Price Target?
The price target for BiomX, Inc. over the next 1-year time period is forecast to be $399.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PHGE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BiomX, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of PHGE?
You can purchase shares of BiomX, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BiomX, Inc. shares.
-
What Is The BiomX, Inc. Share Price Today?
BiomX, Inc. was last trading at $4.69 per share. This represents the most recent stock quote for BiomX, Inc.. Yesterday, BiomX, Inc. closed at $4.77 per share.
-
How To Buy BiomX, Inc. Stock Online?
In order to purchase BiomX, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get PHGE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHGE
Sector
P/E ratio
--
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
18.03x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
PHGE
Sector
Revenue growth
--
4.85%
Earnings growth
-1891.44%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$6.08
-$0.20
Profitability
PHGE
Sector
Profitability FY 2024
-$1.8M
$3.6M
Return on invested capital
-116.24%
-30.98%
Return on assets
-69.56%
-27.62%
Return on equity
-160.84%
-36.69%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
25
Estimated Next Earnings Date
Feb
11
Balance Sheet
PHGE
Sector
Total cash
$7.9M
$27.2M
Short term investments
--
$25.7M
Total assets
$98.8M
$79.9M
Long term debt
$5.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
